Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
e-CBT vs. Pharmacotherapy for Generalized Anxiety Disorder
NCT04478526Completed
- Start
- Apr 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sertraline, escitalopram, pregabalin, duloxetine and venlafaxine in generalized anxiety disorder (GAD) (3 arms). Primary endpoints: State Trait Anxiety Inventory at 6 months, Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form at 6 months and 2 more. Started Apr 2020; status: completed.
02
Drugs
sertralineescitaloprampregabalinduloxetinevenlafaxine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT04478526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04478526.